Competitive and technological changes in the pharmaceutical industry-powerful new drug discoveries, innovative R&D partnerships and marketing plans-are changing the business strategies of many pharma companies. But they face the challenge of spiraling cost of drugs, searching for new drugs, patent expirations and cutting medical care costs. The book also takes a look at the changing face of this industry and profiles the operations of several companies internationally. Cases included are Elly Lilly, Glaxo Wellcome, Merck, Pfizer and Ranbaxy.
ABOUT THE AUTHOR A.V. Vedpuriswar
Dr. A V Vedpuriswar is Dean, ICFI Knowledge Center, Hyderabad. Vedpuriswar holds a B.Tech (Honours) degree in Chemical Engineering from IIT, Kharagpur, a post Graduate Diploma in Management from IIM, Kolkata, the Chartered financial Analyst (CFA) Charter from ICFAI and the PhD degree from Osmania University. Vedpuriswar had earlier worked in Berger Paints (Industrial Marketing) and Tata Steel (International Operations). His areas of interest include International Business, International Finance and business strategy. His research work has a strong global orientation. Besides teaching, Vedpuriswar is also key member of ICFAI’s case development unit, which has emerged as one of the most dynamic case-writing teams in the country. He has authored books like, the global CEO, Enterprise Risk management and innovations in Business Models. He has also edited several volumes of case studied published by the ICFAI University Press. Vedpuriswar was Consulting Editor of “ The Icfaian Journal of Management Research.â€
There are no reviews yet.